Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

NCT06659640

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +19 more
Locations
  • Clinical Trial Site Birmingham, Alabama, United States
  • Clinical Trial Site Cypress, California, United States
  • Clinical Trial Site Gainesville, Florida, United States
  • Clinical Trial Site Indianapolis, Indiana, United States
View all 16 locations
View Trial Details
Active, not recruiting

A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

NCT06693531

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +11 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arizona Digestive Health/GI Alliance Sun City, Arizona, United States
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Scripps Clinic La Jolla, California, United States
View all 54 locations
View Trial Details
Active, not recruiting

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

NCT06922045

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Lanzhou University First Hospital Lanzhou, Gansu, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
View all 18 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

NCT06313593

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • The University of Alabama At Birmingham Birmingham, Alabama, United States
  • Stanford University Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 30 locations
View Trial Details
Active, not recruiting

Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib

NCT04790474

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Emek Medical Center Afula, Israel
  • Rambam Medical Center Haifa, Israel
  • Hadassah Ein-Kerem Medical Center Jerusalem, Israel
  • Shearei Zedek Medical Center Jerusalem, Israel
View Trial Details
Active, not recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

NCT04684108

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Affiliated Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hostipal Beijing, Beijing Municipality, China
  • Shenzhen Second People's Hospital Shenzhen, Guangzhou, China
View all 14 locations
View Trial Details

Related conditions